Literature DB >> 3612550

Dopaminergic modulation of rectosigmoid motility: action of domperidone.

J Wiley, C Owyang.   

Abstract

To investigate the role of dopamine in the modulation of colonic motility we evaluated the effect of dopamine on basal rectosigmoid motor activity before and after treatment with domperidone, phentolamine, propranolol, atropine or placebo in 12 healthy subjects. We also investigated the role of dopamine on the postprandial gastrocolic response. Basal motility index was 126 +/- 38. Dopamine (5-100 micrograms/kg) generated dose-dependent contractions with a frequency of 3 cpm. At 50 micrograms/kg dopamine produced a motility index of 2066 +/- 631. Pretreatment with domperidone (0.4 mg/kg) significantly decreased the amplitude of contractions induced by dopamine but had no effect on the frequency. The motility index was reduced to 668 +/- 148. In contrast atropine, phentolamine and propranolol had no effect on dopamine-stimulated motility. Furthermore, domperidone significantly attenuated the postprandial gastrocolic response compared to placebo. The motility indices of the early and late gastrocolic response were reduced by 65 +/- 12 and 70 +/- 10% of control, respectively. These studies indicate that dopamine stimulates rectosigmoid motility in contrast to its known inhibitory effect on upper gastrointestinal motility. This appears to be mediated by specific dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612550

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Physiology and pathophysiology of colonic motor activity (1).

Authors:  S K Sarna
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 2.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 3.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Chronic constipation: improved understanding offers a new therapeutic approach.

Authors:  Gareth J Sanger
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

Review 5.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

6.  Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.

Authors:  Michelangelo Auteri; Maria Grazia Zizzo; Antonella Amato; Rosa Serio
Journal:  J Physiol Biochem       Date:  2017-06-09       Impact factor: 4.158

Review 7.  Domperidone. A review of its use in diabetic gastropathy.

Authors:  A Prakash; A J Wagstaff
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

8.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

Review 9.  Bladder and bowel dysfunction in Parkinson's disease.

Authors:  R Sakakibara; T Uchiyama; T Yamanishi; K Shirai; T Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-03-10       Impact factor: 3.575

10.  Methionine enhances the contractile activity of human colon circular smooth muscle in vitro.

Authors:  Eun Kyung Choe; Jung Sun Moon; Kyu Joo Park
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.